ALK-Abelló A/S (AKBLF) has a profit margin of 19.88%, below the Healthcare sector average of 21.75%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
As of the most recent data (September 2026), AKBLF shows a profit margin of 19.88%. That compares with 18.11% in the prior-year period — up 9.7% year over year. That is below the Healthcare sector average of 21.75%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AKBLF's profit margin is now 19.88% (was 18.11%) — a 9.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ALK-Abelló A/S is outperforming or lagging.
The Healthcare sector average profit margin is about 21.75%. ALK-Abelló A/S is at 19.88%, which is lower that average. That is roughly 8.6% below the sector mean. Use the comparison chart on this page to see how AKBLF stacks up against individual peers as well.
That compares with 18.11% in the prior-year period — up 9.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare ALK-Abelló A/S with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has ALK-Abelló A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 19.88%) with ownership activity and broader fundamentals.